These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10536489)

  • 1. The effect of glycosaminoglycan sulodexide on oxidative stress and fibrinolysis in diabetes mellitus.
    Skrha J; Perusicová J; Kvasnicka J; Hilgertová J
    Sb Lek; 1998; 99(2):103-9. PubMed ID: 10536489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of simvastatin and fenofibrate on endothelium in Type 2 diabetes.
    Skrha J; Stulc T; Hilgertová J; Weiserová H; Kvasnicka J; Ceska R
    Eur J Pharmacol; 2004 Jun; 493(1-3):183-9. PubMed ID: 15189781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
    Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria.
    Heerspink HL; Greene T; Lewis JB; Raz I; Rohde RD; Hunsicker LG; Schwartz SL; Aronoff S; Katz MA; Eisner GM; Mersey JH; Wiegmann TB;
    Nephrol Dial Transplant; 2008 Jun; 23(6):1946-54. PubMed ID: 18089623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effect of sulodexide, a glycosaminoglycan, on albuminuria in diabetic patients].
    Perusicová J; Skrha J
    Vnitr Lek; 1997 Nov; 43(11):748-52. PubMed ID: 9650507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of glycosaminoglycan sulodexide on albuminuria in patients with diabetes mellitus].
    Oksa A; Pontuch P; Kratochvilova H
    Bratisl Lek Listy; 1999 Sep; 100(9):486-9. PubMed ID: 10645038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alpha-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics.
    Ble-Castillo JL; Carmona-Díaz E; Méndez JD; Larios-Medina FJ; Medina-Santillán R; Cleva-Villanueva G; Díaz-Zagoya JC
    Biomed Pharmacother; 2005 Jul; 59(6):290-5. PubMed ID: 15932790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients.
    Skrha J; Perusicová J; Pont'uch P; Oksa A
    Diabetes Res Clin Pract; 1997 Oct; 38(1):25-31. PubMed ID: 9347243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulodexide oral administration influences blood viscosity and fibrinolysis.
    Crepaldi G; Rossi A; Coscetti G; Abbruzzese E; Calveri U; Calabrò A
    Drugs Exp Clin Res; 1992; 18(5):189-95. PubMed ID: 1490434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
    Singhania N; Puri D; Madhu SV; Sharma SB
    QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in microcirculation and selected laboratory parameters in the early stages of diabetic microangiopathy].
    Skrha J; Prázný M; Kvasnicka J; Kalvodová B
    Cas Lek Cesk; 2001 Jun; 140(12):370-4. PubMed ID: 11503186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale for and study design of the sulodexide trials in Type 2 diabetic, hypertensive patients with microalbuminuria or overt nephropathy.
    Lambers Heerspink HJ; Fowler MJ; Volgi J; Reutens AT; Klein I; Herskovits TA; Packham DK; Fraser IR; Schwartz SL; Abaterusso C; Lewis J;
    Diabet Med; 2007 Nov; 24(11):1290-5. PubMed ID: 17956455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats.
    Kanter M; Coskun O; Korkmaz A; Oter S
    Anat Rec A Discov Mol Cell Evol Biol; 2004 Jul; 279(1):685-91. PubMed ID: 15224410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in patients with essential hypertension.
    Tandon R; Sinha MK; Garg H; Khanna R; Khanna HD
    Natl Med J India; 2005; 18(6):297-9. PubMed ID: 16483028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between tissue factor, its pathway inhibitor and oxidative stress in peritoneal dialysis patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):467-71. PubMed ID: 17581322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-lipoic acid in the treatment of autonomic diabetic neuropathy (controlled, randomized, open-label study).
    Tankova T; Koev D; Dakovska L
    Rom J Intern Med; 2004; 42(2):457-64. PubMed ID: 15529636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.